The Effect of Cholesterol on Membrane-Bound Islet Amyloid Polypeptide
Islet amyloid polypeptide (IAPP) is a proposed cause of the decreased beta-cell mass in patients with type-II diabetes. The molecular composition of the cell-membrane is important for regulating IAPP cytotoxicity and aggregation. Cholesterol is present at high concentrations in the pancreatic beta-c...
Main Authors: | Mikkel Christensen, Nils A. Berglund, Birgit Schiøtt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.657946/full |
Similar Items
-
Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer’s disease: two triggers, one disease
by: Sofia Ferreira, et al.
Published: (2021-01-01) -
Islet amyloid polypeptide does not suppress pancreatic cancer
by: Austin J. Taylor, et al.
Published: (2023-02-01) -
Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease
by: Ana F. Raimundo, et al.
Published: (2020-03-01) -
Contraction of human brain vascular pericytes in response to islet amyloid polypeptide is reversed by pramlintide
by: Cristina Nuñez-Diaz, et al.
Published: (2023-02-01) -
Amyloid-Mediated Mechanisms of Membrane Disruption
by: Michele F. M. Sciacca, et al.
Published: (2021-04-01)